• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Advanced Search Include Citations

Tools

Sorted by:
Try your query at:
Semantic Scholar Scholar Academic
Google Bing DBLP
Results 1 - 10 of 4,410
Next 10 →

Cytological Alterations and Antitumoral Activity

by A. Bravo-cuellar, G. Balercia, J. P. Levesque, Et Al, Contact The Aacr Publications, A. Bravo-cuellar, G. Balercia, J. P. Levesque, X. H. Liu, F. Osculati, S. Orbach-arbouys
"... Peritoneal macrophages from mice injected with aclacinomycin (ACM) (4 mg/kg, i.p.) showed increased functional activity, as assessed by increased antitumoral activity in vitro and in vivo and zymosan-triggered chemoluminescence. They also showed ultrastructural signs of activation (increased number ..."
Abstract - Add to MetaCart
Peritoneal macrophages from mice injected with aclacinomycin (ACM) (4 mg/kg, i.p.) showed increased functional activity, as assessed by increased antitumoral activity in vitro and in vivo and zymosan-triggered chemoluminescence. They also showed ultrastructural signs of activation (increased number

Evaluation of the Antitumor Activity of Gemcitabine

by Larry W. Hertel, George B. Boder, J. Stan Kroin, Et Al, Contact The Aacr Publications, Larry W. Hertel, George B. Boder, J. Stan Kroin, Sharon M. Rinzel, Gerald A. Poore, Glen C. Todd, Gerald B. Grindey , 2013
"... A new pyrimidine antimetabolite, 2',2'-difluorodeoxycytidine, Gem citabine (LY188011, dFdCyd) has been synthesized and evaluated in experimental tumor models. dFdCyd is a very potent and specific deoxy cytidine analogue. The concentration required for 50 % inhibition of growth is 1 ng/ml i ..."
Abstract - Add to MetaCart
agent. Maximal activity in vivo was seen with dFdCyd when administered on an every third day schedule. 1-/3-D-Arabinofuranosylcytosine, administered on a daily for 10-day sched ule, was directly compared to dFdCyd in this evaluation. dFdCyd dem onstrated good to excellent antitumor activity in eight

IN VITRO ANTIOXIDANT AND ANTITUMOR ACTIVITY OF

by Google Scholar, Embase Etc, Shonima Govindan M, Jiji Thomas, G Muraleedhara Kurup
"... journal published quarterly. The Aim of IJPBS is to publish peer reviewed research and review articles in less time without much delay in the developing field of Pharmaceutical and Biological sciences. One week from the date of manuscript submission author gets the decision of acceptance and if acce ..."
Abstract - Add to MetaCart
journal published quarterly. The Aim of IJPBS is to publish peer reviewed research and review articles in less time without much delay in the developing field of Pharmaceutical and Biological sciences. One week from the date of manuscript submission author gets the decision of acceptance and if accepted the manuscript will be processed within 3 weeks (approx.) for publication.

the antitumor activity of NB1011

by Christopher R Boyer, Patricia L Karjian, Geo¡rey M Wahl, Mark Pegram, Saskia Tc Neuteboom
"... p-nitrobenzylthioinosine, selectively potentiate ..."
Abstract - Add to MetaCart
p-nitrobenzylthioinosine, selectively potentiate

cisplatin antitumor activity in head

by Jong-lyel Roh, Eun Hye Kim, Jin Young Park, Ji Won Kim, Minsu Kwon, Byung-heon Lee
"... selectively kills cancer cells and increases ..."
Abstract - Add to MetaCart
selectively kills cancer cells and increases

induce additive antitumor activity

by Michael Koldehoff, Dietrich W. Beelen, Ahmet H. Elmaagacli
"... Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA ..."
Abstract - Add to MetaCart
Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA

and Antitumor Activity in a

by Marta Cesca, Roberta Frapolli, Er Berndt, Valentina Scarlato, Petra Richter, Hartwig Kosmehl, Anderson J. Ryan, Raffaella Giavazzi, Ovarian Carcinoma
"... reduced tumor burden in the peritoneal cavity of mice and sig-nificantly increased their survival. Analysis of vascular changes and PTX tumor uptake in vandetanib-treated tumors may help to guide the scheduling of vandetanib plus PT n of clinical trials with these drugs. Neoplasia (2009) 11, 1155–11 ..."
Abstract - Add to MetaCart
reduced tumor burden in the peritoneal cavity of mice and sig-nificantly increased their survival. Analysis of vascular changes and PTX tumor uptake in vandetanib-treated tumors may help to guide the scheduling of vandetanib plus PT n of clinical trials with these drugs. Neoplasia (2009) 11, 1155–1164

ANTITUMOR ACTIVITY OF THE CARBOPLATIN-o-CYCLODEXTRIN

by Weiping Liu, Huizhou Xiong, Yikun Yang, Ling Li, Zhiqiang Shen, Zhihe Chen
"... Antitumor activity of the adduct between Carboplatin and (z-cyclodextrin has been tested against Sarcoma 180 ($18o) and Ehrlich ascites carcinoma (EAC) murine tumors. The preliminary toxicity has also been evaluated by histological examinations of the treated animals. The results show the adduct has ..."
Abstract - Add to MetaCart
Antitumor activity of the adduct between Carboplatin and (z-cyclodextrin has been tested against Sarcoma 180 ($18o) and Ehrlich ascites carcinoma (EAC) murine tumors. The preliminary toxicity has also been evaluated by histological examinations of the treated animals. The results show the adduct

Antitumor Activities of Kushen: Literature Review

by Mingyu Sun , Hongyan Cao , Lin Sun , Shu Dong , Yanqin Bian , Jun Han , Lijun Zhang , Shuang Ren , Yiyang Hu , Chenghai Liu , Lieming Xu , Ping Liu
"... To discover and develop novel natural compounds with therapeutic selectivity or that can preferentially kill cancer cells without significant toxicity to normal cells is an important area in cancer chemotherapy. Kushen, the dried roots of Sophora flavescens Aiton, has a long history of use in tradi ..."
Abstract - Add to MetaCart
activities were identified in KS-Fs than in KS-As in vitro and in vivo. KS-Fs may be developed as novel antitumor agents.

Synthesis and Antitumor Activity of Poly(organophosphazene)/

by Doxorubicin Conjugates, Soo-chang Song, Chong Ok Lee, Youn Soo Sohn , 1998
"... Doxorubicin shows a wide spectrum of activity for solid tumors such as sarcomas, adenocarcinomas and melanomas, but its strong side effects including myelosuppression, extravasation reaction and cardiotoxicity have been a serious problem.1 Polymer-anticancer drug conjugates have been studied in orde ..."
Abstract - Add to MetaCart
~5 In addition, polymer-anticancer drug conju-gates can afford to prolong the antitumor activity by releas-ing the drug with a controlled rate. Several polymer-doxorubicin conjugates have been studied, and among them, N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer/ doxorubicin conjugate is currently under
Next 10 →
Results 1 - 10 of 4,410
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University